Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
[Clinical aspects and observations on patients with lymphadenopathy syndrome]
Dtsch Med Wochenschr. 1984 Dec 21;109(51-52):1955-62. Unique Identifier : AIDSLINE MED/85076294 Helm EB; Bergmann L; Elbert M; Mitrou P; Stille W
Abstract:
Since November 1982, patients with symptoms suggesting a lymphadenopathy syndrome (LAS) or acquired immune deficiency syndrome (AIDS), as well as their contacts and persons in high risk groups were examined as out-patients. The examinations have now been concluded in 101 patients. The patients were divided into 3 groups according to clinical symptoms and the OKT4+/OKT8+ ratio: 30 patients with normal ratio (group I), 59 patients with LAS and a ratio of less than 1 (group II) and 12 patients with fully developed AIDS (group III). During a follow-up time of 18 months, 3 patients of group I developed LAS and 1 patient in group II developed toxoplasma encephalitis. In a further 2 patients with LAS, uncharacteristic symptoms such as fever, tiredness and loss of weight increased, while at the same time the number of OKT4+ cells and thus the ratio fell significantly. In 4 cases the immunological parameters and the clinical picture improved. In 52 patients the clinical picture and the laboratory findings did not change. The demonstration of retrovirus HTLV III would seem to provide the cause of LAS and AIDS. Nonetheless, follow-up observation of contacts and patients with LAS remain important.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Adolescence Adult Antibodies, Monoclonal/IMMUNOLOGY English Abstract Female Homosexuality Human Lymphatic Diseases/*IMMUNOLOGY Male Middle Age Risk JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.